Bayer

In a strategic move to expand its therapeutic offerings and bolster its footprint in the Indian pharmaceutical market, CORONA Remedies has acquired the rights to seven established brands from global healthcare major Bayer. The transaction is expected to enhance CORONA’s presence in key segments such as dermatology, gastroenterology, and anti-infectives. The acquisition reflects a broader trend of Indian pharma companies consolidating portfolios by acquiring legacy brands with strong brand recall.

German life sciences giant Bayer AG has announced the launch of BICOTA, an innovative pest management product targeting stem borers, a major threat to rice crops in India. Scheduled for release in June 2025 across 11 key rice-growing states including Punjab, Haryana, West Bengal, and Tamil Nadu, BICOTA promises longer-lasting protection with a single application while promoting root and tiller development.

Safex Chemicals has entered into a strategic partnership with Bayer under the Better Life Farming initiative, aimed at improving agricultural practices for small farmers in India. The collaboration will focus on upskilling farmers in Bihar, Uttar Pradesh, and other underserved regions, introducing cost-effective crop protection and nutrition solutions tailored to local needs. This initiative aligns with Safex's broader vision of enhancing productivity, sustainability, and farmer income.